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ABSTRACT
Introduction Chronic spinal pain (CSP) is the most 
common musculoskeletal disorder and is a leading cause 
of disability as per the Global Burden of Diseases. Previous 
reviews of microscopic changes in the spinal extensor 
muscles of people with CSP have focused on the lumbar 
region only and the results have been inconclusive. 
Therefore, in this protocol, we aim to assess microscopic 
changes in the extensor muscles of all spinal regions, 
investigating regionally specific changes in muscle fibre 
types of the spinal extensor muscles in patients with non- 
specific CSP.
Methods/analysis This protocol was designed using 
Preferred Reporting Items for Systematic Review and 
Meta- Analysis Protocols (PRISMA- P) guidelines. Searches 
will use the following databases: MEDLINE, Embase, 
PubMed, CINAHL Plus and Web of Science along with 
relevant grey literature searches. Two reviewers will 
conduct the searches, perform data extraction, apply 
inclusion criteria and conduct risk of bias assessment 
using Newcastle- Ottawa Scale. Data will be synthesised 
and analysed independently. If there is sufficient 
homogeneity, then meta- analysis will be conducted by 
the reviewers jointly. If not, meta- synthesis or narrative 
reporting will be performed. The quality of the evidence 
will be assessed using Grading of Recommendations, 
Assessment, Development and Evaluation (GRADE) 
guidelines.
Ethics and dissemination The results of this study will 
be submitted for publication to a peer- reviewed journal 
and will be presented at conferences. Ethical approval for 
this systematic review was not required due to no patient 
data being collated.
PROSPERO registration number CRD42020198087.
INTRODUCTION
Chronic spinal pain (CSP) is one of the most 
common musculoskeletal disorders with a 
lifetime prevalence of 54% to 80%.1 CSP is the 
leading cause of disability2 and apart from the 
impact on quality of life, it produces a massive 
socioeconomic burden.1 3–8 In most cases of 
CSP, no specific nociceptive source can be 
found and a diagnosis of non- specific chronic 
pain or persistent pain is provided.7 9 As per 
the National Institute for Health and Care 
Excellence (NICE) guidelines, chronic pain 
is defined as any long term pain or persistent 
pain that ‘persists or recurs for longer than 3 
months’.10 11
Low back pain (LBP) is the most common 
spinal pain complaint with a lifetime preva-
lence of 84%. The second most common 
spinal pain complaint is neck pain, with up 
to 70% of people experiencing at least one 
episode of neck pain in their lifetime.1 12 
In the case of thoracic spinal pain, though 
considered a common complaint and simi-
larly disabling like lumbar and cervical spinal 
pain, the associated epidemiology is not well 
documented.13
Structural changes have been observed 
in the spinal musculature in people experi-
encing CSP compared with an asymptomatic 
population. These changes can occur on 
a macroscopic or microscopic level within 
the muscle. Macroscopic changes include 
fatty infiltration, reduced cross sectional 
area (CSA) or atrophy. Microscopic changes 
include remodelling of muscle fibre types, 
Strengths and limitations of this study
 ► This is the first systematic review to investigate the 
microscopic changes in the spinal extensor muscu-
lature of the cervical, thoracic and lumbar regions in 
a chronic spinal pain population.
 ► This review allows for comparison of microscopic 
changes within and between different regions of the 
spine.
 ► This review will use the Newcastle- Ottawa Scale 
which is the most suitable tool to assess the risk of 
bias across various observational studies.
 ► While it would also be valuable to consider the mac-
roscopic changes in the spinal musculature, this 
review will be limited to microscopic changes only.
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change in their size and distribution.14–17 These changes 
may lead to reduced function and have implications for 
ongoing pain and disability.18 19 A comprehensive under-
standing of the macroscopic and microscopic features of 
the skeletal muscles in the spinal region in people with 
CSP is needed to better understand the pathophysiology 
associated with chronic pain.18
Five systematic reviews have examined changes in macro-
scopic features of spinal musculature in people with CSP 
including changes in the CSA of muscles, fatty infiltration 
and muscle atrophy using various imaging techniques.20–24 
Two of these reviews were specific to LBP20 24 and one of 
these two also examined changes in microscopic features 
of spinal musculature.24 Ranger et al, reported conflicting 
evidence to support an association between the CSA of 
spinal muscles and LBP.20 They also reported that the 
CSA of multifidus had a negative association with LBP 
intensity and was predictive of the occurrence of LBP 
for up to 12 months in men.20 Goubert et al, reported 
that paraspinal muscular atrophy was present in people 
with chronic LBP, except for the erector spinae.24 There 
were also inconsistent results regarding fatty infiltration 
of lumbar muscles in LBP in both these studies20 24 but 
both reviews consistently documented atrophy of multif-
idus in people with chronic LBP. Two of the five system-
atic reviews examined macroscopic changes of the neck 
musculature in people with neck pain.21 22 De Pauw et al 
reviewed morphological changes using ultrasonography 
and MRI in chronic non- specific neck pain as well as in 
whiplash associated disorders (WAD). This work revealed 
that the neck extensor muscles have decreased CSA in 
people with non- specific neck pain, yet increased CSA in 
WAD.21 They also found evidence for fatty infiltration in 
the extensor muscles in WAD and a cephalocaudal decline 
of fat in the suboccipital muscles in people with chronic 
neck pain, with the exception of the multifidus.21 25 The 
most recent review by Farrell et al, assessing the muscula-
ture of the cervical spine in WAD and non- specific neck 
pain by MRI, could not draw any conclusions mostly due 
to low quality of evidence (owing to small sample sizes 
and greater heterogeneity). However, they reported a 
significantly decreased CSA of the rectus capitis posterior 
major muscle in people with chronic neck pain compared 
with controls.22
Overall, since these systematic reviews conducted on 
the macroscopic features of the paraspinal musculature 
are high quality reviews (exhibiting moderate to high 
confidence on AMSTAR 2 tool scoring26), we are confi-
dent in what these studies conclude regarding macro-
scopic changes in people with CSP.
In contrast, only two systematic reviews have studied 
microscopic features (eg, quantification of the propor-
tional area of different fibre types within a muscle based 
on size and distribution) of the spinal musculature in 
people with CSP and both were focused on LBP only.19 24 
The review by Cagnie et al yielded inconclusive results for 
fibre typing between different intrinsic lumbar muscles, 
however, some evidence in this review suggested that the 
CSA occupied by type 1 fibres in women was relatively 
higher compared with men in both healthy and patients 
with LBP.19 It should be noted that this review included 
studies which were not limited to chronic non- specific 
LBP and the inclusion criteria did not consider the quality 
of the selected studies. Goubert et al concluded that there 
was no fibre type abnormalities in the paraspinal muscles 
of people with chronic LBP, but this review considered 
only case–control studies which is indicative of restricted 
evidence.24 No previous systematic review has examined 
microscopic changes in the spinal musculature in the 
cervical or thoracic region.
Thus, here we aim to systematically review the primary 
studies examining muscle fibre type distribution in 
people with CSP considering the cervical, thoracic and 
lumbar regions. Specifically, our objectives are to:
a. Assess muscle fibre type composition and density/pro-
portion of muscle fibre types within the spinal exten-
sor muscles in patients experiencing CSP compared 
with healthy controls.
b. Compare muscle fibre type composition and density/
proportion of muscle fibre types in the spinal extensor 
muscles across different regions of the spine in people 
with chronic neck, thoracic or low back pain.
METHODS
Design
This systematic review was designed using PRISMA- P 
guidelines (Preferred Reporting Items for System-
atic Reviews and Meta- Analysis Protocols)(online 
supplemental file 1)27 and in accordance with the 
Cochrane Handbook for Systematic Reviews.28 29 This 
protocol is registered under PROSPERO, ID number 
CRD42020198087.
Inclusion criteria
In order to report the characteristics of the study, 
the adapted Population, Intervention, Comparison, 
Outcomes and Study (PICOS) framework30 was used to 
develop the eligibility criteria.
 ► Population: Studies including adult’s ≥18 years of 
age experiencing non- specific CSP. For this review 
purposes, spinal pain is considered chronic if 
persisting >3 months as per NICE guidelines.10 Spinal 
regions considered for this review include cervical, 
thoracic and lumbar regions.
 ► Comparator: Studies must compare the microscopic 
changes in the spinal extensor musculature (cervical, 
thoracic or lumbar region) and this comparison 
could be with healthy controls (≥18 years) or between 
different extensor muscles of the spine or the same 
muscle in different regions of the spine.
 ► Outcome: The muscle fibre type composition and/or 
density/proportion of muscle fibre types in extensor 
muscles of the spine. The muscles of interest are the 
intrinsic muscles of the back, for example, erector 
spinae and multifidus.
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 ► Study design: Observational studies will likely consti-
tute the highest level of evidence for this review, as 
ascertained by scoping searches.
Exclusion criteria
 ► Studies including specific spinal pain due to acute 
trauma, fractures, surgeries, deformities like scoliosis, 
kyphosis, lordosis or pathologies like inflammatory 
disorders, infection and malignancy, or other relevant 
pathologies.
 ► Studies comparing exercises/interventions while 
looking for microscopic changes in spinal muscles, as 
these studies are investigating the influence of exer-
cise on muscle fibres in back pain rather than the 
influence of back pain on muscle fibres.
 ► Studies that are not in English language.
 ► Studies where the full text is not available.
Information sources
Electronic databases MEDLINE (Ovid Interface), 
Embase, PubMed, CINAHL Plus and Web of Science 
will be searched for relevant studies. Searches will be 
conducted from database inception until March 2021. 
Key journals including Journal of Anatomy, The Spine 
Journal, European Spine Journal and the Clinical Journal 
of Pain will be searched. Any anticipation of publication 
bias will be assessed by searching thoroughly for unpub-
lished literature from conference proceedings from 
2018 to 2020, including Society for Back Pain Research 
Annual Meeting and the World Institute of Pain. Grey 
literature searching will be conducted by searching the 
Open Grey and British National bibliography databases. 
Hand searching of reference lists from eligible studies 
will also be carried out. Study authors from the included 
studies will be contacted through email for any details if 
necessary.
Search strategy
Search strategies has been developed using free- text or 
MeSH (MedicalSubject Headings) terms applying PICOS 
criteria for specific databases. An example of a compre-
hensive search strategy developed for the MEDLINE 
(Ovid) database is detailed in box 1. The lead author 
(SP) will conduct the searches from all the information 




The abstracts and citations of all potentially relevant 
studies obtained from the literature search will be 
imported into EndNote X9 (Clarivate Analytics) data 
management software. Full- texts of all potentially eligible 
studies after review of titles and abstracts will be imported 
into Endnote X9 for thorough screening. The search 
strategy was based on the eligibility criteria.
Selection process
Following the removal of duplicates, two reviewers (SP/
AS) will independently screen all the eligible studies 
to assess each studies’ suitability for inclusion in this 
review. In the first stage, the title and abstract of all 
studies obtained from search results will be screened 
and ineligible studies will be excluded. All potentially 
eligible studies, and any studies where eligibility is 
unclear following title and abstract screening, will be 
Box 1 Comprehensive search strategy developed for 
MEDLINE (Ovid) database.
1. exp Neck Pain/ or exp Back Pain/ or exp Chronic Pain/ or spinal 
pain.mp. or exp Low Back Pain/
2. exp Chronic Pain/ or exp Back Pain/ or chronic back pain.mp. or 
exp Low Back Pain/
3. exp Back Pain/ or exp Low Back Pain/ or persistent back pain.mp.
4. exp Neck Pain/ or exp Back Pain/ or cervical spinal pain.mp. or exp 
Low Back Pain/
5. neck pain.mp. or exp Neck Pain/
6. exp Chronic Pain/ or exp Neck Pain/ or chronic neck pain.mp.
7. exp Neck Pain/ or persistent neck pain.mp. or exp Chronic Pain/
8. exp Back Pain/ or exp Low Back Pain/ or thoracic spinal pain.mp.
9. Spinal Diseases/ or persistent thoracic spine pain.mp.
10. exp Low Back Pain/ or lumbar spinal pain.mp. or exp Chronic Pain/ 
or exp Back Pain/
11. lumbago.mp. or exp Low Back Pain/
12. exp Chronic Pain/ or exp Low Back Pain/ or exp Back Pain/ or low* 
back pain.mp.
13. exp Low Back Pain/ or exp Back Pain/ or chronic low* back pain.
mp. or exp Chronic Pain/
14. exp Chronic Pain/ or exp Low Back Pain/ or persistent low* back 
pain.mp.
15. exp Low Back Pain/ or exp Back Pain/ or LBP.mp.
16. exp Low Back Pain/ or CLBP.mp. or exp Chronic Pain/
17. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 
14 or 15 or 16
18. exp Muscle Fibers, Slow- Twitch/ or exp Muscle Fibers, Fast- Twitch/ 
or exp Muscle Fibers, Skeletal/ or muscle fibre type.mp.
19. exp Muscle Fibers, Fast- Twitch/ or exp Muscle Fibers, Slow- Twitch/ 
or exp Muscle Fibers, Skeletal/ or muscle fiber type.mp. or exp 
Myosin Heavy Chains/
20. exp Muscle Fibers, Skeletal/ or fibre size.mp.
21. fiber size.mp. or exp Muscle Fibers, Skeletal/ or exp Muscular 
Atrophy/
22. fibre distribution.mp. or exp Muscle Fibers, Skeletal/
23. exp Muscle Fibers, Skeletal/ or fibre area.mp.
24. fiber characteristics.mp. or exp Myosin Heavy Chains/ or exp 
Muscle Fibers, Skeletal/
25. exp Muscle Fibers, Fast- Twitch/ or exp Muscle Fibers, Skeletal/ or 
exp Muscle Fibers, Slow- Twitch/ or fibre characteristics.mp.
26. exp Muscle Fibers, Skeletal/ or fibre proportion.mp.
27. muscle fibre density.mp. or exp Muscle Fibers, Skeletal/
28. exp Muscle Fibers, Slow- Twitch/ or exp Muscle Fibers, Fast- Twitch/ 
or exp Muscle Fibers, Skeletal/ or fibre type composition.mp.
29. exp Muscle Fibers, Skeletal/ or microscopy of back muscle*.mp.
30. 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29
31. 17 and 30
32. limit 31 to humans
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further screened for eligibility by reading the full text. 
Any disagreement between reviewers at each stage will 
be discussed between reviewers. If reviewers are unable 
to reach consensus, then the third reviewer (DF) will be 
consulted to make a decision.
Data collection process
Following the screening process, all relevant information 
will be extracted from each included study by the lead 
author (SP), following which accuracy will be checked by 
the second reviewer (AS). A standardised data extraction 
form has been developed based on the Cochrane data 
extraction template and guided by the objectives and 
inclusion criteria of the review. This form will be piloted 
on a small number of studies to confirm the complete-
ness of data extraction.
Data items
Data extraction items of interest to this review are 
summarised in table 1, and includes: author (study ID), 
the title of the paper, year of publication, country of 
study, source of funding, aims/objectives of the study, 
study design, sample size, characteristics of patient and 
control population, spinal pain characteristics, details 
of biopsy samples, analysis and outcome measures from 
the studies, muscle fibre type, distribution, fibre size, 
proportional area of different fibre types, any other fibre 
characteristics confounding factors and study limitations. 
If any data is omitted or ambiguous from the studies 
or its results affecting its eligibility, then the respective 
author will be contacted via email for clarifications. If 
there is no response from the author within 2 weeks, a 
reminder email will be sent allowing a further 2 weeks for 
a response. If there is still no response then the study will 
not be considered for inclusion but it will be noted as 
excluded for ambiguity, with specific reason noted.
Outcomes and prioritisation
The primary outcome that will be considered in this 
review is the muscle fibre type distribution (Type 1 - slow 
twitch- oxidative, Type II a - fast twitch- oxidative glycolytic, 
Type II b (II x) - fast twitch- glycolytic, Type II c - inter-
mediate) and the proportional area of different fibre 
types determined by the fibre size and distribution in 
spinal extensor muscles of patients with CSP. We will also 
consider additional outcomes such as gender differences 
within these results (if there are sufficient primary studies 
addressing this).
Risk of bias in individual studies
Risk of Bias (RoB) will be assessed by the two reviewers 
independently using the Newcastle- Ottawa Scale (NOS). 
Since this review anticipates observational studies, the 
NOS is the most suitable tool as this is developed to assess 
the quality of observational studies.31 When we identify 
the study designs used, we will ensure that the version of 
the NOS used matches the design of the evidence (eg, 
using the case–control or cohort versions). The NOS 
considers three main categories for the scoring system 
which include selection, comparability and outcome/
exposure. Under selection, a study can get maximum of 4 
stars, maximum of 2 stars for comparability and maximum 
3 stars for outcome.31 There are thresholds for converting 
NOS to the Agency for Healthcare Research and Quality 
standards.31 According to these, a study can be graded 
as (1) Good quality: if selection category scores 3 or 4 
stars AND comparability scores 1 or 2 stars AND outcome 
scores 2 or 3 stars; (2) Fair quality: selection scores 2 stars 
AND comparability scores 1 or 2 stars AND outcome 
scores 2 or 3 stars; (3) Poor quality: selection scores 0 or 
1 star OR comparability scores 0 stars OR outcome scores 
0 or 1 stars.
Though previous studies have raised questions on its 
reliability and unknown validity,32 33 there is growing use 
of NOS because of its ease and suitability in systematic 
reviews.33 Therefore, for this review, the NOS will be used 
as it is widely used and designed for use across observa-
tional studies.
Data synthesis
The data synthesis in this review will be influenced by the 
methodology and the results of all the studies included. 
If there is homogeneity in the methodology and outcome 




  Title of the study
  Year of publication
  Country of study
  Source of funding
  Aims/objectives of the study
Methodology Study design
  Sample size
  Patient population characteristics - age, 
gender, diagnosis, confounding factors (like 
restriction of activity level)
  Control population characteristics - age, 
gender, any confounding factors
  Spinal pain characteristics - average 
duration of pain, laterality, severity
  Biopsy samples - type of biopsy done and 
how muscle sample was obtained (eg, 
surgical, ultrasound guided,), from which 
muscle, landmark site/location taken from, 
unilateral or bilateral region
Synthesis of 
results
Analysis and outcome measures - fibre type 
(I, IIa, IIb/IIc, IIx) slow, intermediate or fast 
twitch, fibre type percentage/ distribution, 
fibre size, area occupied by fibre types, any 
other fibre characteristics if mentioned
Study 
limitations
Confounding factors, observational bias, 
measurement techniques
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measures of studies, then meta- analysis will be consid-
ered. However, this decision can be made only following 
the data extraction. The meta- analysis will be completed 
if there is sufficient homogeneity in the following factors:
 ► Measurement technique for muscle fibre type meas-
ured as a percentage of distribution or as the propor-
tional area occupied by each fibre type or by fibre size.
 ► Which muscles were studied? - Biopsies/muscle 
samples taken from different muscles of the same 
region or same muscle from different region or 
different muscles from different regions.
 ► Which population was considered? .
 ► Age group- young adults, middle age or older adults.
 ► Pain- related factors, if mentioned in studies, such as 
pain intensity, activity/disability level which may influ-
ence the muscle morphology.
Where sufficient homogeneity is reached in the points 
above, meta- analysis will be conducted considering the 
following outcomes:
 ► Comparing a common histological outcome in the 
same extensor muscles across different regions of the 
spine (eg, multifidus, erector spinae).
 ► Comparing a common histological outcome in 
different extensor muscles of the same spinal region.
Reviewers will independently assess the homogeneity of 
the included studies and group/subgroup them appro-
priately for analysis of outcome measures. Further clarity 
on whether there are enough studies to analyse the 
areas of interest, and how best studies can be grouped/
subgrouped appropriately for precise comparisons, 
will be determined following data extraction. For meta- 
analysis, first the reviewers will independently determine 
the grouping, justifying where precise comparisons can 
be made based on outcome measures. If there is lack of 
clarity on the homogeneity of a study, inclusion will be 
decided by joint consensus. Assessment for subgroup 
analysis will also be considered in a similar manner (eg, 
comparison between men and women with LBP). If there 
are discrepancies between the two reviewers on inclusion 
of certain studies in the meta- analysis or subgroup anal-
ysis, or whether or not to conduct the meta- analysis at all, 
then a third reviewer (DF) will determine the potential 
for meta- analysis.34
If reviewers decide it may be suitable to carry out the 
meta- analysis, a statistical test for heterogeneity will be 
conducted to calculate the I2 value which will determine 
the total variation across the studies as a percentage.35 I2 
value can be around 25%, 50% or 75% indicating low, 
moderate or high heterogeneity between studies, respec-
tively.29 35 Similar to previous reviews, we will proceed with 
meta- analysis if the I2 value is <50%.34 36
If meta- analysis is determined to be pertinent, the 
outcome results from all the eligible studies will be 
collected in a systematic way. As we are investigating 
a binary outcome, that is, muscle fibre type changes 
present or absent in CSP, ORs will likely be the most suit-
able statistical approach.37 ORs will be used to investigate 
the relationship between muscle fibre types and CSP, 
clarifying the existence of muscle fibre type changes in 
CSP compared with healthy controls.
If the reviewers agree not to conduct meta- analysis 
due to the heterogeneity of pooled data, then meta- 
synthesis will be considered under expert guidance.34 If 
the eligible studies cannot be pooled to conduct meta- 
synthesis, we would then consider presenting our find-
ings in a narrative way. In narrative reporting, there will 
be full interpretation of the findings for each outcome 
measure. The clinical and statistical significance of each 
outcome measure, as well as the RoB assessments of indi-
vidual studies will be considered. The findings will be 
summarised for all outcomes of interest and inferences 
drawn from the overall direction of effect.
Confidence in cumulative evidence
The Grading of Recommendations Assessment, Devel-
opment and Evaluation (GRADE) approach will be 
applied to assess the quality of evidence.38 GRADE tool 
will be carried out as per the guidelines for our outcome 
measures identified previously. The GRADE approach 
determines the overall cumulative quality of the evidence 
across individual studies based on five determinants - (1) 
risk of bias,39 (2) inconsistency - heterogeneity in studies 
in the review (eg, population, age group, chronicity and 
severity of spinal pain),40 (3) indirectness - for example, 
the use of results from cadaveric samples in some studies, 
(4) imprecision - with larger the sample sizes indicating 
greater precision41 and finally (5) publication bias - 
arising from non- publication of relevant results.42 Since 
it is anticipated that most of the included studies will be 
observational studies with case–control, cohort and cross- 
sectional designs, these studies are given a ‘low’ rating 
initially in the GRADE framework. The study can be 
downgraded or upgraded depending on the above deter-
minants and subsequently, quality of evidence will be 
graded as either very low (+), low (++), moderate (+++) 
or high (++++) according to the GRADE guidelines.38 
Quality of evidence can also be upgraded based on the 
large effect sizes or a large number of studies indicating 
the same direction of effect for the muscle fibre type 
distribution or the area occupied by the fibre types.
Patient and public involvement
The research question in this study forms part of a larger 
discussion within our patient and public involvement 
meetings. Patients will not be involved in the analysis and 
data collection of the systematic review.
Discussion of implications of this study
Studies have shown that pain can affect muscle behaviour 
which has the potential to induce histological/structural 
changes in the muscle fibres.43 These changes include alter-
ations in the muscle fibre size and distribution and potentially 
transformation of fibre types.44 Some studies have suggested 
that changes in the size and distribution of different muscle 
fibre types are associated with the duration of pain14 17 45 
whereas others did not find any association.46 Some studies 
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found significant differences in proportional area occupied 
by different fibre types46 and some did not.17 This systematic 
review aims to provide a comprehensive understanding of 
our current knowledge of microscopic changes in the spinal 
musculature in people with CSP. This knowledge can help 
to direct exercise prescription for the management of CSP 
with the aim of improving muscle function and potentially 
reverting ‘pathological’ or ‘adverse’ changes in muscle fibre 
type.
Ethics and dissemination
No research ethics is required for this systematic review due 
to no patient data being collated. Results of this review will 
be submitted to be published in a peer- review journal and 
presented at conferences.
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